miR-27a-mediated antiproliferative effects of metformin on the breast cancer cell line MCF-7
Authors:
- 24 October 2016
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 36 (6) , 3691-3699
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 38 references indexed in Scilit:
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysisPLOS ONE, 2012
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast CancerDiabetes Care, 2010
- MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitinCancer Letters, 2009
- MicroRNA and cardiac pathologiesPhysiological Genomics, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- The Oncogenic microRNA-27a Targets Genes That Regulate Specificity Protein Transcription Factors and the G2-M Checkpoint in MDA-MB-231 Breast Cancer CellsCancer Research, 2007
- Epigenetics and MicroRNAsPediatric Research, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodiesNature Cell Biology, 2005
- The blooming of the French lilacJournal of Clinical Investigation, 2001